

NCT02940912 comparison:

Summary:
CHIA has 25 criteria while your personal folder has 25 criteria
Total found criteria: 25/25
Total not Found: 0/25
Total Extra: 5
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Idiopathic Parkinson's disease ( Hughes AJ et al.  │ Idiopathic Parkinson's disease ( Hughes AJ et al.  │
│ 2001)                                              │ 2001)                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with motor fluctuations                   │ Patients with motor fluctuations                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic Insomnia disorder criteria according to    │ Chronic Insomnia disorder criteria according to    │
│ the criteria of DMS- V ( American Psychiatric      │ the criteria of DMS- V ( American Psychiatric      │
│ Association, 2013) and insomnia severity index >   │ Association, 2013) and insomnia severity index \>  │
│ 15                                                 │ 15                                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Able to use independently the device required for  │ Able to use independently the device required for  │
│ treatment by apomorphine                           │ treatment by apomorphine                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Collection of written informed consent (legal      │ Collection of written informed consent (legal      │
│ obligation for any project under the public health │ obligation for any project under the public health │
│ law , bioethics laws and / or CNIL)                │ law , bioethics laws and / or CNIL)                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Affiliate to social security or beneficiary of     │ Affiliate to social security or beneficiary of     │
│ such a regime                                      │ such a regime                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Atypical Parkinsonian Syndromes                    │ Atypical Parkinsonian Syndromes                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Parkinson's disease with hallucinations            │ Parkinson's disease with hallucinations            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Parkinson's disease with impulse Control disorder  │ Parkinson's disease with impulse Control disorder  │
│ (ICD)                                              │ (ICD)                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Parkinson's disease already treated with           │ Parkinson's disease already treated with           │
│ APOMORPHINE pump or justifying the use of the pump │ APOMORPHINE pump or justifying the use of the pump │
│ continuously day and night                         │ continuously day and night                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Another obvious severe disease explaining insomnia │ Another obvious severe disease explaining insomnia │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Exclusion for monitoring difficulties (mutation,   │ Exclusion for monitoring difficulties (mutation,   │
│ insufficient motivation, priority associated       │ insufficient motivation, priority associated       │
│ pathology in care)                                 │ pathology in care)                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient unwilling to accept a pump                 │ Patient unwilling to accept a pump                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient not accepting polysomnography and multiple │ Patient not accepting polysomnography and multiple │
│ sleep latency test                                 │ sleep latency test                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient with health problems or a skin disease     │ Patient with health problems or a skin disease     │
│ precluding continuous subcutaneous infusion        │ precluding continuous subcutaneous infusion        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female parturient or nursing                       │ Female parturient or nursing                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Cardiac dysrhythmia precluding treatment with      │ Cardiac dysrhythmia precluding treatment with      │
│ domperidone or apomorphine (increased QTc = 440 ms │ domperidone or apomorphine (increased QTc ≥ 440 ms │
│ in men, QTc = 450 ms in women)                     │ in men, QTc ≥ 450 ms in women)                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ antiemetic neuroleptics                            │ antiemetic neuroleptics                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Tetrabenazine                                      │ Tetrabenazine                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Excessive alcohol consumption                      │ Excessive alcohol consumption                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hypersensitivity to apomorphine or one of the      │ Hypersensitivity to apomorphine or one of the      │
│ excipients                                         │ excipients                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Respiratory Depression                             │ Respiratory Depression                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatic impairment                                 │ Hepatic impairment                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intellectual Disability                            │ Intellectual Disability                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Dementia                                           │ Dementia                                           │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                              │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Parkinson's disease with dementia (Montreal Cognitive Assessment (MoCA) \<25/30 (NASREDDINE and al., │
│ 2012))                                                                                               │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Treatments forbidden in association with apomorphine such as                                         │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Contraindications for apomorphine                                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have maximum age of 90 Years                                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 35 Years                                                                    │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛